Department of Neurology, Hakodate Municipal Hospital, Japan.
Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.
Intern Med. 2021 Dec 1;60(23):3801-3804. doi: 10.2169/internalmedicine.7448-21. Epub 2021 Jun 5.
A 56-year-old woman presenting with type II respiratory failure was transferred to our hospital. She did not exhibit muscle weakness or elevated serum myogenic enzymes, but needle electromyography revealed myogenic changes in the limb muscles, and her blood tests were positive for anti-mitochondrial antibodies (AMA). Muscle histopathological findings included immune-mediated necrotizing myopathy, so she was diagnosed with inflammatory myopathy associated with AMA. After treatment with corticosteroids and noninvasive positive pressure ventilation, her symptoms improved. If a diagnosis of type II respiratory failure is difficult, inflammatory myopathy associated with AMA should be considered as a differential diagnosis.
一位 56 岁女性因 II 型呼吸衰竭转入我院。她没有出现肌肉无力或血清肌源性酶升高,但针极肌电图显示肢体肌肉有肌源性改变,且血抗线粒体抗体(AMA)阳性。肌肉组织病理学发现包括免疫介导的坏死性肌病,因此诊断为 AMA 相关炎性肌病。予皮质类固醇和无创正压通气治疗后,症状改善。如果 II 型呼吸衰竭的诊断困难,应考虑 AMA 相关炎性肌病作为鉴别诊断。